You are here: Industry Insights > Pain

News List

NICE publishes new guidance on chronic pain management pharmatimes
April 15, 2021
The UK National Institute for Health and Care Excellence (NICE) has published new guidance on the assessment of chronic pain, recommending exercise instead of commonly used drugs such as paracetamol as part of its guidelines.
Therapix, University of Calgary to Evaluate Proprietary Drug Candidate for Pain americanpharmaceuticalreview
December 24, 2020
Therapix Biosciences announced a collaboration between the company and The University of Calgary to further evaluate the analgesic effect of Therapix's CB2R agonist proprietary drug candidate, THX-160.
EicOsis Successfully Completes Phase 1a Clinical Trial of EC5026 americanpharmaceuticalreview
December 01, 2020
EicOsis Human Health announced the successful completion of a Phase 1a single-ascending dose clinical trial of EC5026, their oral drug candidate for the treatment of pain.
Pacira Receives EC Approval for EXPAREL for Postsurgical Pain americanpharmaceuticalreview
November 26, 2020
Pacira BioSciences announced the European Commission has granted marketing authorization for EXPAREL as a brachial plexus block or femoral nerve block for treatment of post-operative pain in adults, and as a field block for treatment of ...
New Study: Postoperative Pain Can Be Reduced by Using NOL Monitoring to Guide Analgesic Medication During Surgery prnasia
September 30, 2020
A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain.
Pacira Receives Positive CHMP Opinion for EXPAREL for Postsurgical Pain americanpharmaceuticalreview
September 27, 2020
Pacira BioSciences announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending marketing authorization for EXPAREL for postsurgical analgesia.
FDA Approves New Opioid for Intravenous Use in Hospitals, Other Clinical Settings americanpharmaceuticalreview
August 14, 2020
The U.S. Food and Drug Administration (FDA) approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom ...
Over 90 percent of medical marijuana in US contains high levels of THC, study finds europeanpharmaceuticalreview
March 30, 2020
A study conducted in the US has revealed that the majority of medical marijuana dispensed in the US has THC levels of up to 15 percent.
Biohaven drug wins US FDA approval for use in relieving migraine headaches expresspharma
March 03, 2020
A single oral dose of the 75 mg tablet can provide fast pain relief, return patients to normal function within an hour, and remain effective for up to 48 hours for many patients, the company said.
Four Weeks of Active TENS Beneficial for Fibromyalgia drugs
January 20, 2020
Four weeks of active transcutaneous electrical nerve stimulation (TENS) results in significant improvement in movement-evoked pain and other clinical outcomes compared with placebo-TENS or no TENS ...

Previous page 1 2 3 4 5 6 Next page